Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Advises Stockholders To Take No Action In Response To Roche's New Offer

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) suggested that its stockholders take no action at this time in response to announcement by Roche Holding AG (RHHBY.PK) that it is now offering to acquire Illumina for $51.00 per share in cash.

Earlier, on February 7, 2012, Illumina's Board of Directors rejected Roche's $44.50 per share cash tender offer and recommended that stockholders not tender their shares.

Illumina stated that its Board of Directors will thoroughly review Roche's revised proposal and make a recommendation to stockholders regarding the proposal in due course.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that it swung to a second quarter loss, hurt by higher costs and expenses even as revenue surged 47%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Kraton Performance Polymers, Inc. (KRA), Wednesday reported second-quarter net income of $11.1 million or $0.33 per share, up from $3.8 million or $0.12 per share last year. Adjusted earnings improved to $0.46 per share from $0.15 per share last year. Revenues for the quarter dropped to $323.8... Organic grocer Whole Foods Market, Inc. said Wednesday after the markets closed that its third quarter profit rose 6.3% from last year, as same-store sales increased 3.9%. The company's quarterly earnings per share also came in above analysts' expectations, but its quarterly sales fell shy of analyst' forecast.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.